Tumorendoprothetik am distalen Femur: Indikationen und operative Technik

Zusammenfassung

Das distale Femur ist neben dem proximalen Femur und der proximalen Tibia ein Prädilektionsort für die Manifestaion von primär malignen und benignen/aggressiven Knochentumoren [11] der Extremitäten sowie eine Hauptlokalisation für metastatische Destruktionen. Bei malignen Skeletttumoren des distalen Femurs ist eine rasche Einleitung der Diagnostik zur Abklärung der Tumorbiologie (Entität und Grading) von essenzieller Bedeutung und determiniert die weitere onkologische Systembehandlung und tumororthopädische Lokaltherapie. Fehlerhaft durchgeführte Biopsien können falsch-negative Diagnosen erbringen und führen – wenn nicht nach bestimmten Richtlinien durchgeführt – zu schlechtem funktionellem Ergebnis nach Resektion, können den Extremitätenerhalt gefährden und beeinträchtigen die Prognose des Patienten. Chirurgisch stehen nach intra-/extraartikulärer weiter Resektion heutzutage vielfältige Rekonstruktionsmöglichkeiten zur Verfügung. Der tumorendoprothetische Ersatz stellt dabei das am häufigsten durchgeführte Rekonstruktionsverfahen nach Exzision kniegelenknaher Tumoren des distalen Femurs dar. Durch den distalen Femurersatz ist ein Extremitätenerhalt mit funktioneller und belastungsstabiler Wiederherstellung der Kniegelenkbeweglichkeit möglich. Er findet Anwendung zur Rekonstruktion bei massiven gelenknahen osteolytischen Destruktionen, bei pathologischen Frakturen, periprothetischen Frakturen oder in der Revisionsendoprothetik. Den Vorteilen einer raschen Mobilisation, sofortigen Vollbelastung, guter Funktion und kurzen Rehabilitationszeit stehen die zu erwartenden Revisionseingriffe bei erhöhter Komplikationsrate mit erhöhtem Infektionsrisiko (Megaprothese) sowie aseptische Lockerungen und Implantatversagen (inkl. Kopplungsmechanismus und PE-Inlays) gegenüber.

Abstract

Along with the proximal femur and the proximal tibia, the distal femur is the most affected site for the manifestation of primary malignant and benign/aggressive bone tumours [11] of the extremities, as well as being a principle site of metastatic destruction. In malignant, skeletal tumors of the distal femur, rapid initiation of complete diagnostic measures is essential for assessment of tumour biology (entity and grading) and guidance of the further oncological treatment, including both systemic and local orthopaedic therapy. Incorrectly performed biopsies can lead to false negative diagnosis, usually result in poor functional outcome, can compromise salvage of the extremity and adversely affect the patientʼs prognosis. After intra- or extraarticular resection, a wide range of surgical options is available. Following excision of tumours around the knee joint, endoprosthetic distal femur replacement is the most frequently performed reconstruction procedure and allows functional restoration of knee joint mobility. Distal femur replacement is typically performed in patients with massive osteolytic destruction, in pathological and periprosthetic fractures or for revision of total knee replacements. Rapid mobilisation without loading restrictions, a good range of motion and short rehabilitation periods are the advantages of the procedure. However, in comparison to conventional knee arthroplasty, distal femur replacement is associated with increased rates of complication, such as infection, aseptic loosening and hardware failure.

• Literatur

• 1 Aguilar JA, Paley J, Santpure S. et al. Clinical validation of the multiplier method for predicting limb length at maturity, part I. J Pediatr Orthop 2005; 25: 186-191
• 2 Bacci G, Ferrari S, Longhi A. et al. Non-metastatic osteosarcoma of the extremity with pathological fracture: Local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand 2003; 74: 449-454
• 3 Bielack S, Jürgens H, Jundt G. et al. Osteosarcoma: the COSS experience. Cancer Treat Res 2009; 152: 289-308
• 4 Bus MP, van de Sande MA, Fiocco M. et al. What are the long-term results of MUTARS® modular endoprostheses for reconstruction of tumor resection of the distal femur and proximal tibia?. Clin Orthop Relat Res 2017; 475: 708-718
• 5 Capanna R, Morris HG, Campanacci D. et al. Modular uncemented prosthetic reconstruction after resection of tumours of the distal femur. J Bone Joint Surg Br 1994; 76: 178-186
• 6 Chandrasekar CR, Grimer RJ, Carter SR. et al. Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Joint Surg Br 2009; 91: 108-112
• 7 Cole AS, Hill GA, Theologis TN. et al. Femoral nailing for metastatic disease of the femur: a comparison of reamed and unreamed femoral nailing. Injury 2000; 31: 25-31
• 8 Donati F, Di Giacomo G, Ziranu A. et al. Silver coated prosthesis in oncological limb salvage surgery reduce the infection rate. J Biol Regul Homeost Agents 2015; 29 (04) (Suppl.) S149-S155
• 9 Enneking WF, Spanier SS, Goodman MA. Current concepts review. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg Am 1980; 62: 1027-1030
• 10 Etchebehere M, Lin PP, Bird JE. et al. Patellar resurfacing does it affect outcomes of distal femoral replacement after distal femoral resection?. J Bone Joint Surg Am 2016; 98: 544-551
• 11 Freyschmidt J, Ostertag H, Jundt G. Knochentumoren: Klinik, Radiologie, Pathologie. Berlin, Heidelberg, New York: Springer; 1998
• 12 Futani H, Minamizaki T, Nishimoto Y. et al. Long-term follow-up after limb salvage in skeletally immature children with a primary malignant tumor of the distal end of the femur. J Bone Joint Surg Am 2006; 88: 595-603
• 13 Gebert C, Hardes J, Hoffmann C. et al. Chirurgische Therapieoptionen bei malignen Knochentumoren. Chirurg 2002; 73: 1162-1169
• 14 Gosheger G, Gebert C, Ahrens H. et al. Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 2006; 450: 164-171
• 15 Grimer RJ, Carter SR, Tillmann RM. et al. Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg Br 1999; 81: 488-494
• 16 Grimer RJ, Aydin BK, Wafa H. et al. Very long-term outcomes after endoprosthetic replacement for malignant tumours of bone. Bone Joint J 2016; 98-B: 857-864
• 17 Guder W, Hardes J, Gosheger G. et al. Osteo- und Chondrosarkome des Beckens und der unteren Extremitäten. Chirurg 2015; 86: 993-1003
• 18 Guzik G. Results of the treatment of bone metastases with modular prosthetic replacement – analysis of 67 patients. J Orthop Surg Res 2016; 11: 20
• 19 Hage WD, Aboulafia AJ, Aboulafia DM. Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am 2000; 31: 515-528
• 20 Hardes J, Gebert C, Hillmann A. et al. [Rotationplasty in the surgical treatment plan of primary malignant bone tumors. Possibilities and limits]. Orthopade 2003; 32: 965-970
• 21 Hardes J, Gebert C, Schwappach A. et al. Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg 2006; 126: 289-296
• 22 Hardes J, von Eiff C, Streitbuerger A. et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol 2010; 101: 389-395
• 23 Hardes J, Ahrens H, Gosheger G. et al. Komplikationsmanagement bei Megaprothesen. Unfallchirurg 2014; 117: 607-613
• 24 Heisel C, Kinkel S, Bernd L. et al. Megaprostheses for the treatment of malignant bone tumours of the lower limbs. Int Orthop 2006; 30: 452-457
• 25 Henderson ER, Groundland JS, Pala E. et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am 2011; 93: 418-429
• 26 Hillmann A, Hoffmann C, Gosheger G. et al. Malignant tumor of the distal part of the femur or the proximal part of the tibia: endoprosthetic replacement or rotationplasty. Functional outcome and quality-of-life measurements. J Bone Joint Surg Am 1999; 81: 462-468
• 27 Holzer G, Windhager R, Kotz R. One-stage revision surgery for infected megaprostheses. J Bone Joint Surg Br 1997; 79: 31-35
• 28 Höll S, Schlomberg A, Gosheger G. et al. Distal femur and proximal tibia replacement with megaprosthesis in revision knee arthroplasty: a limb-saving procedure. Knee Surg Sports Traumatol Arthrosc 2012; 20: 2513-2518
• 29 Jeys LM, Grimer RJ, Carter SR. et al. Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am 2005; 87: 842-849
• 30 Kawai A, Lin PP, Boland PJ. et al. Relationship between magnitude of resection, complication, and prosthetic survival after prosthetic knee reconstructions for distal femoral tumors. J Surg Oncol 1999; 70: 109-115
• 31 Leonard HA, Liddle AD, Burke O. Single- or two-stage revision for infected total hip arthroplasty? A Systematic review of the literature. Clin Orthop Relat Res 2014; 472: 1036-1042
• 32 Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 2006; 64: 1121-1127
• 33 Mittermayer F, Krepler P, Dominkus M. et al. Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Relat Res 2001; 388: 167-177
• 34 Myers GJ, Abudu AT, Carter SR. et al. Endoprosthetic replacement of the distal femur for bone tumours: long-term results. J Bone Joint Surg Br 2007; 89: 521-526
• 35 Plotz W, Rechl H, Burgkart R. et al. Limb salvage with tumor endoprostheses for malignant tumors of the knee. Clin Orthop Relat Res 2002; 405: 207-215
• 36 Pohlig F, Kirchhoff C, Lenze U. et al. Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a retrospective study. Eur J Med Res 2012; 17: 29
• 37 Schaser KD, Bail HJ, Haas NP. et al. Treatment concepts of benign bone tumors and tumor-like bone lesions. Chirurg 2002; 73: 1181-1190
• 38 Schmolders J, Koob S, Schepers P. et al. [The role of a modular universal tumour and revision system (MUTARS®) in lower limb endoprosthetic revision surgery – outcome analysis of 25 patients]. Z Orthop Unfall 2016;
• 39 Streitburger A, Gosheger G, Dieckmann R. et al. Bone defect reconstruction in bone sarcoma surgery: tumour endoprosthesis versus biological reconstruction. Unfallchirurg 2014; 117: 600-606
• 40 Winkelmann W. Orthopädie und orthopädische Chirurgie. Tumoren, tumorähnliche Erkrankungen. Stuttgart, New York: Thieme; 2005